The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 11,529 | 318,565 | SH | SOLE | 318,565 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 97,469 | 12,033,220 | SH | SOLE | 12,033,220 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 39,623 | 1,547,152 | SH | SOLE | 1,547,152 | 0 | 0 | ||
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,155 | 336,134 | SH | SOLE | 336,134 | 0 | 0 | ||
| AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 19,394 | 1,292,940 | SH | SOLE | 1,292,940 | 0 | 0 | ||
| AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 970 | 114,039 | SH | SOLE | 114,039 | 0 | 0 | ||
| ALCOBRA LTD | SHS | M2239P109 | 5,051 | 2,044,756 | SH | SOLE | 2,044,756 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 29,285 | 2,191,977 | SH | SOLE | 2,191,977 | 0 | 0 | ||
| ARCA BIOPHARMA INC | COM PAR$.001 | 00211Y407 | 1,476 | 521,606 | SH | SOLE | 521,606 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 42,263 | 3,266,045 | SH | SOLE | 3,266,045 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 11,212 | 1,525,424 | SH | SOLE | 1,525,424 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 73,998 | 3,681,491 | SH | SOLE | 3,681,491 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 12,599 | 707,426 | SH | SOLE | 707,426 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 71,387 | 1,732,274 | SH | SOLE | 1,732,274 | 0 | 0 | ||
| AXOVANT SCIENCES LTD | COM | G0750W104 | 70,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 5,238 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 13,185 | 2,989,795 | SH | SOLE | 2,989,795 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 14,280 | 2,428,571 | SH | SOLE | 2,428,571 | 0 | 0 | ||
| DIMENSION THERAPEUTICS INC | COM | 25433V105 | 12,369 | 1,548,033 | SH | SOLE | 1,548,033 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 4,743 | 354,200 | SH | SOLE | 354,200 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 16,854 | 1,820,138 | SH | SOLE | 1,820,138 | 0 | 0 | ||
| MERUS N V | COM | 98978L204 | 3,433 | 204,929 | SH | SOLE | 204,929 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 62,950 | 3,664,154 | SH | SOLE | 3,664,154 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 15,941 | 754,411 | SH | SOLE | 754,411 | 0 | 0 | ||
| PROTEON THERAPEUTICS INC | COM | 74371L109 | 15,179 | 1,626,931 | SH | SOLE | 1,626,931 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 4,164 | 899,438 | SH | SOLE | 899,438 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 13,059 | 2,501,667 | SH | SOLE | 2,501,667 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 5,532 | 2,389,700 | SH | SOLE | 2,389,700 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 35,845 | 4,631,114 | SH | SOLE | 4,631,114 | 0 | 0 | ||
| WAVE LIFE SCIENCES PTE LTD | SHS | Y95308105 | 230,168 | 7,088,651 | SH | SOLE | 7,088,651 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 28,018 | 2,451,237 | SH | SOLE | 2,451,237 | 0 | 0 | ||